Skip to search formSkip to main contentSkip to account menu

interferon alfa/ritonavir/stavudine

Known as: d4T/IFN-A/RIT 
National Institutes of Health

Related topics

Related topics

5 relations
Interferon-alphaNorvirRecombinant Interferon AlfaRitonavir

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
Nanoparticle-in-microparticle oral drug delivery system of a clinically relevant darunavir/ritonavir antiretroviral combination.
2017
2017
Effects of individual differences in working memory on performance and trust with various degrees of automation
ABSTRACT Previous studies showed performance benefits with correct automation, but performance costs when the automation was… 
2015
2015
Recombinant Immunotoxin with T-cell Epitope Mutations That Greatly Reduce Immunogenicity for Treatment of Mesothelin-Expressing Tumors
SS1P is a recombinant immunotoxin (RIT) that targets mesothelin. It consists of an antimesothelin Fv fused to a portion of… 
2014
2014
Synthesis of poly[N-(2-hydroxypropyl)methacrylamide] conjugates of inhibitors of the ABC transporter that overcome multidrug resistance in doxorubicin-resistant P388 cells in vitro.
The effects of novel polymeric therapeutics based on water-soluble N-(2-hydroxypropyl)methacrylamide copolymers (P(HPMA)) bearing… 
2013
2013
Preclinical evaluation of NETA-based bifunctional ligand for radioimmunotherapy applications using 212Bi and 213Bi: radiolabeling, serum stability, and biodistribution and tumor uptake studies.
2006
2006
Approximate dynamic programming methods for an inventory allocation problem under uncertainty
We propose two approximate dynamic programming methods to optimize the distribution operations of a company manufacturing a… 
Highly Cited
2003
Highly Cited
2003
Combination therapy with Pretarget CC49 radioimmunotherapy and gemcitabine prolongs tumor doubling time in a murine xenograft model of colon cancer more effectively than either monotherapy.
Pretarget radioimmunotherapy (RIT) is a multistep strategy for cancer therapy designed to reduce nontarget organ exposure by… 
Highly Cited
2002
Highly Cited
2002
A Phase I study of combined modality (90)Yttrium-CC49 intraperitoneal radioimmunotherapy for ovarian cancer.
PURPOSE The purpose of this study was to determine the feasibility and maximum tolerated dose of (90)Yttrium-CC49 ((90)Y-CC49) as… 
1997
1997
Timing effects of combined radioimmunotherapy and radiotherapy on a human solid tumor in nude mice.
Timing effects of radioimmunotherapy (RIT) combined with external-beam radiotherapy (RT) were assessed in human colon carcinoma… 
Highly Cited
1987
Highly Cited
1987
Sickle-cell trait as a risk factor for sudden death in physical training.
Case reports of sudden death during exertion have not established an association between the sickle-cell trait (hemoglobin AS… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)